News

The US Food and Drug Administration plans to strengthen the warning label on lymphoma drug Adcetris over concerns that it may be linked to a rare, but deadly brain infection. At the time of...

AstraZeneca has entered into a three-year collaboration agreement with healthcare information and technology provider IMS Health. The collaboration will see both companies boost the use of real-world evidence throughout Europe in order to improve...

GlaxoSmithKline (GSK) will appeal to the Supreme Court of Argentina against a ruling issued by Judge Marcelo Aguinsky over the inadequate handling of administrative conduct during the firm's Clinical Otitis Media and Pneumonia study in 2007-08. ...

Lexicon Pharmaceuticals has announced the top-line results from the first clinical study evaluating the combined effects of LX4211, a sodium glucose transporter 1 and 2 (SGLT1 and SGLT2) inhibitor, with dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin. ...

Apricus Biosciences has signed a licensing deal with Abbott Laboratories, as per which Abbott will receive the exclusive rights to market Apricus Bio's Vitaros  in Canada. Vitaros (alprostadil), indicated to treat erectile dysfunction (ED) is...

Novartis AG said Sunday it is voluntarily recalling some over-the-counter products in the U.S., including its Excedrin headache pills and NoDoz medication, because they may contain broken or stray tablets from other products. The...

CanBas Co, a clinical-stage biopharmaceutical company, has received orphan drug designation fro the United States Food and Drug Administration (FDA) for it's CBP501 "for use in combination with cisplatin and pemetrexed for treatment of patients with mesothelioma. ...